NDC 17856-0672-04 - Ondansetron
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-0672
- Requested NDC
- 17856-0672-04
- Package NDCs from labels
- 17856-0672-1, 17856-0672-2, 17856-0672-3, 17856-0672-4, 17856-0672-04
- Manufacturer
- Atlantic Biologics Corp.
- Effective date
- 2025-10-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ondansetron - Atlantic Biologics Corp. | Atlantic Biologics Corp. | 2025-10-23 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0672-1 | Ondansetron | 60 in 1 CASE | SOLUTION | 60 | 1 | |
| 17856-0672-1 | Ondansetron | 2.5 mL in 1 SYRINGE | SOLUTION | 2.5 | 1 | |
| 17856-0672-2 | Ondansetron | 120 in 1 CASE | SOLUTION | 120 | 1 | |
| 17856-0672-2 | Ondansetron | 2.5 mL in 1 SYRINGE | SOLUTION | 2.5 | 1 | |
| 17856-0672-3 | Ondansetron | 120 in 1 CASE | SOLUTION | 120 | 1 | |
| 17856-0672-3 | Ondansetron | 2.5 mL in 1 SYRINGE | SOLUTION | 2.5 | 1 | |
| 17856-0672-4 | Ondansetron | 72 in 1 CASE | SOLUTION | 72 | 1 | |
| 17856-0672-4 | Ondansetron | 5 mL in 1 CUP, UNIT-DOSE | SOLUTION | 5 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17856-0672-1 | ML - Milliliter | 17856-0672 | f5b97fd9-6050-46e6-b0da-693821d3938a | 1 | 2026-03-17 |
| 17856-0672-2 | ML - Milliliter | 17856-0672 | 787cc894-2cc2-4952-981c-f67609a087e3 | 1 | 2026-03-17 |
| 17856-0672-3 | ML - Milliliter | 17856-0672 | 53831650-5a50-4e31-9590-1c0ac60dc7ec | 1 | 2026-03-17 |
| 17856-0672-4 | ML - Milliliter | 17856-0672 | 68c3eadb-fcbb-40cc-80d0-0ddc4021b83a | 1 | 2026-02-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| WE FRESH Lubricating Eye Drops | GLYCERIN | Oculus Surgical, Inc. | 4f253b5d-001b-091e-e063-6394a90a9d39 | 2026-04-09 | Warnings | PDC6A3C0OX |
| Ondansetron | ONDANSETRON | Hikma Pharmaceuticals USA Inc. | c29ca6df-621d-44b6-98fc-b48666573366 | 2026-04-09 | Warnings, Adverse reactions | NMH84OZK2B |
| Sore Throat | PHENOL GLYCERIN | Walgreens | 1e845299-178e-49ce-9d08-7e9d548a5a6d | 2026-04-09 | Warnings | PDC6A3C0OX |
| Thera Plus Hemorrhoidal | GLYCERIN, PHENYLEPHRINE HYDROCHLORIDE, PRAMOXINE HYDROCHLORIDE, WHITE PETROLATUM | Fourstar Group USA, Inc. | 5d63bf97-29d2-4c71-97c3-85f425e86207 | 2026-04-07 | Warnings | PDC6A3C0OX |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | Sportpharm LLC | b1324076-f83e-4816-9e02-6b2a689010bc | 2026-04-05 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron | ONDANSETRON | PAI Holdings, LLC dba PAI Pharma | 68a4d845-0c1c-4867-bfca-c0fb11dc93cd | 2026-03-31 | Warnings, Adverse reactions | 312085 NMH84OZK2B |
| Redness Relief | GLYCERIN, NAPHAZOLINE HCL | Pharmadel LLC | 4c113bb9-814f-d92d-e063-6294a90a8302 | 2026-03-30 | Warnings | PDC6A3C0OX |
| Moisture Oyster | GLYCERIN | Moisture Oyster Inc | 4e45317a-437f-4d88-e063-6294a90a98d0 | 2026-03-30 | Warnings | PDC6A3C0OX |
| Aveeno Skin Relief Healing | GLYCERIN | Kenvue Brands LLC | 345fdde5-700b-7103-e063-6394a90a0e3e | 2026-03-27 | Warnings | PDC6A3C0OX |
| Crocodile Tears Lubricant Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | Crocodile Tears LLC | 4df29336-ea0c-0484-e063-6294a90a685a | 2026-03-26 | Warnings | PDC6A3C0OX |
| Artificial Tears Lubricant Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | KC Pharmaceuticals, Inc | 4de5c844-85ca-ff9f-e063-6394a90ac12c | 2026-03-25 | Warnings | PDC6A3C0OX |
| Lemon Glycerin | GLYCERIN | Dynarex Corporation | 99fc00ea-9d55-0380-e053-2995a90a2c0b | 2026-03-24 | Warnings | PDC6A3C0OX |
| ONDANSETRON | ONDANSETRON | HF Acquisition Co LLC, DBA HealthFirst | 4dcd1e4c-6a9c-7ac6-e063-6394a90a39bf | 2026-03-24 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron | ONDANSETRON | JVET PHARMACEUTICALS LLC | 95ca0d81-a0a8-441d-820e-cb6624018a15 | 2026-03-23 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron | ONDANSETRON | REMEDYREPACK INC. | 36592150-7e19-474c-9f96-cc8341e28b5d | 2026-03-20 | Warnings, Adverse reactions | NMH84OZK2B |
| Drop20 | FUCUS VESICULOSUS, CHELIDONIUM MAJUS, KALI PHOSPHORICUM, LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, QUERCUS GLANDIUM SPIRITUS, QUERCUS ROBUR, NUX VOMICA, PHYTOLACCA DECANDRA, ORNITHOGALUM UMBELLATUM, AGNUS CASTUS, BERBERIS AQUIFOLIUM, BERBERIS VULGARIS, SACCHARUM OFFICINALE, SOLIDAGO VIRGAUREA, CALCAREA CARBONICA, CARBO VEGETABILIS, MAGNESIA PHOSPHORICA, NATRUM PHOSPHORICUM, SINAPIS ARVENSIS, FLOS, UBIDECARENONUM, GRAPHITES, HYPOPHYSIS SUIS, PLACENTA TOTALIS SUIS, HYPOTHALAMUS (BOVINE) | Pick Enterprises Corp | baa96813-dc95-472e-a834-880a0cd484a7 | 2026-03-13 | Warnings | C151H8M554 |
| Ondansetron HCL | ONDANSETRON HCL | Advanced Rx of Tennessee, LLC | af735f22-6d6c-6e1f-e053-2a95a90a3532 | 2026-03-13 | Warnings, Adverse reactions | NMH84OZK2B |
| Appetrol 20 | FUCUS VESICULOSUS, CHELIDONIUM MAJUS, KALI PHOSPHORICUM, LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, QUERCUS GLANDIUM SPIRITUS, QUERCUS ROBUR, NUX VOMICA, PHYTOLACCA DECANDRA, ORNITHOGALUM UMBELLATUM, AGNUS CASTUS, BERBERIS AQUIFOLIUM, BERBERIS VULGARIS, SACCHARUM OFFICINALE, SOLIDAGO VIRGAUREA, CALCAREA CARBONICA, CARBO VEGETABILIS, MAGNESIA PHOSPHORICA, NATRUM PHOSPHORICUM, SINAPIS ARVENSIS, FLOS, UBIDECARENONUM, GRAPHITES, HYPOPHYSIS SUIS, PLACENTA TOTALIS SUIS, HYPOTHALAMUS (BOVINE) | Carbalor LLC | d66234a3-2477-42be-8f7b-283e3a5f87ed | 2026-03-12 | Warnings | C151H8M554 |
| Optimel Manuka Dry Eye Drops | GLYCERIN | Melcare Biomedical Pty Ltd | 88c5e2f0-9f7e-62d1-e053-2995a90a9014 | 2026-03-11 | Warnings | PDC6A3C0OX |
| Optimel Manuka Forte Eye Gel | GLYCERIN | Melcare Biomedical Pty Ltd | 8e0ed6e8-51fc-7c5b-e053-2a95a90a35a9 | 2026-03-11 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.